Important Information

THIS WEBSITE IS INTENDED FOR INSTITUTIONAL INVESTORS who are U.S. residents ONLY; not intended for access or distribution to retail investors.

 

In order to access the Capital Group U.S. Institutional website (the “Site”), please read the following information and affirm by clicking the accept button that you have read and understand the information provided.

 

You must attest that you meet the qualifications of an institutional investor as described herein and accept these Terms and Conditions in order to access the Site. Some content may require additional registration for access.

 

The Site is solely intended for U.S. residents who are institutional investors or are acting on behalf of an institutional investor who has agreed to these Terms and Conditions. Institutional investors include, but are not limited to any person acting on behalf of/any pension fund, financial intermediary, consultant, endowment and foundation, bank, savings and loan association, insurance company, investment company registered under the Investment Company Act of 1940, investment adviser registered with the U.S. Securities and Exchange Commission or under applicable state law, government entity, entity with total assets of at least $50 million, employee benefit or qualified retirement plan with at least 100 participants, defined contribution/benefit plan, and qualified client or purchaser as defined by the U.S. Securities and Exchange Commission. By agreeing to these Terms and Conditions you are affirming your understanding that the Site is not intended for retail investors, individual plan participants or others who may not possess the financial sophistication to independently understand the content nor should it be redistributed to such persons.

 

You understand that the Site does not constitute advice of any nature, including fiduciary investment advice by Capital Group or its associates.

 

The reference to “Capital Group” used herein includes The Capital Group Companies, Inc., and its affiliates.

Investment Fund

BACK TO FUND'S DETAIL PAGE

All Holdings

2122 Total Holdings:
As of 9/30/24
All Holdings: 1 - 15 of 2122
Security Name Asset Type Shares or
Principal Amount 		Market Value Percent of
Net Assets descending arrow
Capital Group Central Cash Fund Short Term 45,073,871 $4,508,288,531.00 4.08%
Broadcom, Inc. Equity 26,119,771 $4,505,660,498.00 4.07%
Philip Morris International, Inc. Equity 23,990,151 $2,912,404,331.00 2.63%
AbbVie, Inc. Equity 13,628,349 $2,691,326,361.00 2.43%
Capital Group Central Corporate Bond Fund Investment Fund 303,272,365 $2,626,338,685.00 2.38%
Microsoft Corp. Equity 4,818,673 $2,073,474,992.00 1.88%
RTX Corp. Equity 15,840,524 $1,919,237,888.00 1.74%
VICI Properties, Inc. REIT Equity 54,713,621 $1,822,510,716.00 1.65%
Taiwan Semiconductor Manufacturing Co., Ltd. Equity 50,779,820 $1,550,291,679.00 1.4%
JPMorgan Chase & Co. Equity 6,952,935 $1,466,095,874.00 1.33%
Abbott Laboratories Equity 11,893,783 $1,356,010,200.00 1.23%
Gilead Sciences, Inc. Equity 16,046,558 $1,345,343,423.00 1.22%
Amgen, Inc. Equity 3,674,347 $1,183,911,347.00 1.07%
Zurich Insurance Group AG Equity 1,965,149 $1,185,434,667.00 1.07%
Exxon Mobil Corp. Equity 9,787,949 $1,147,343,382.00 1.04%
All Holdings: 1 - 15 of 2122